MENU
ELEV
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Elevation Oncology (ELEV) Ownership - Who owns Elevation Oncology?
Elevation Oncology Inc is an oncology company focused on the development of selective cancer therapies to treat patients across a range of solid tumors with unmet medical needs... Show more
Profile
Industry
N/A
Address
101 Federal Street
Phone
+1 716 371-1125
Employees
29
Web
https://www.elevationoncology.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
15.51M
P/E Ratio
N/A
Total Cash
93.18M
Projected Growth
N/A
Total Debt
31.13M
Revenue
N/A
Risk (Beta)
1.00
Dividend Yield
N/A
Total Cash/Share
1.57
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
ELEV
Capitalization
15.5M
P/E Ratio
N/A
Risk (Beta)
1.00
Dividend Yield
N/A
Total Cash
93.2M
Total Cash/Share
1.57
Total Debt
31.1M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
60M
P/B Ratio
0.26
Cash Flow
N/A
Earnings
-0.78
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
6K
Current Ratio
21.21
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-40.42M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-48.17
Shares Held By Institutions
23.7M
Shares Outstanding - Current
59.2M
Total Liabilities
35.6M
Total Volume MTD
N/A
Value
1
Gain YTD
-53.431
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
101 Federal Street
Phone
+1 716 371-1125
Employees
29
Web
https://www.elevationoncology.com